baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Revance Therapeutics/ US7613301099 /

6/18/2024 9:59:50 PM	Chg. +0.01	Volume	Bid-	Ask-	High	Low
2.81USD	+0.36%	9,458 Turnover: 26,569.45	-Bid Size: -	-Ask Size: -	2.89	2.75

GlobeNewswire 3/28 ArriVent BioPharma Reports Full Year 2023 Financial Results

GlobeNewswire 11/5/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeu...

GlobeNewswire 10/27/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeu...

GlobeNewswire 10/19/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeu...

GlobeNewswire 9/25/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Revance Therapeu...

GlobeNewswire 9/20/2023 ArriVent Appoints Chris Nolet to its Board of Directors

GlobeNewswire 2/8/2022 FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Re...

GlobeNewswire 2/8/2022 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been F...

GlobeNewswire 2/7/2022 Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Dead...

GlobeNewswire 2/5/2022 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Revance Therapeutics (RVNC) Investors to Lead Plaint...

GlobeNewswire 2/4/2022 RVNC Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Revance Therapeutics, Inc. Invest...

GlobeNewswire 2/3/2022 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BLI, RAAS, RVNC INVESTORS of Lead Plaintiff Deadline in Class...

GlobeNewswire 2/3/2022 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rev...

GlobeNewswire 2/2/2022 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors with Losses to S...

GlobeNewswire 2/2/2022 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BLI, RAAS an...

GlobeNewswire 2/1/2022 DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investo...

GlobeNewswire 2/1/2022 SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS HOOD, MARA, RAAS, RVNC INVESTORS...

GlobeNewswire 2/1/2022 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revanc...

GlobeNewswire 1/31/2022 RVNC 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics ...

GlobeNewswire 1/29/2022 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BLI, RAAS, RVNC INVESTORS of Lead Plaintiff Deadline in Class...

GlobeNewswire 1/29/2022 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sle...

GlobeNewswire 1/29/2022 Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behal...

GlobeNewswire 1/28/2022 RVNC Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Revance Therapeutics, Inc. Invest...

GlobeNewswire 1/27/2022 SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS HOOD, MARA, RAAS, RVNC INVESTORS...

GlobeNewswire 1/27/2022 Final Deadline Approaching on LP Deadline Date: Kessler Topaz Meltzer & Check, LLP Reminds Revance T...

Revance Therapeutics/ US7613301099 /

If you wish to receive reply to your feedback, please provide your email address.